News FDA clears GSK's Priorix, first new MMR vaccine in 50 years With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmi
News Ipsen charts $1.75bn course for Kartos acquisition Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
